Karyopharm Therapeutics Inc. sell Lokrim
Start price
11.12.21
/
20%
€5.24
Target price
11.12.22
-
Performance (%)
-16.73%
End price
08.12.22
€4.37
Summary
This prediction ended on 08.12.22 with a price of €4.37. The prediction for Karyopharm Therapeutics Inc. closed with a convincing performance of -16.73%. Lokrim has 20% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Karyopharm Therapeutics Inc. | -1.930% | -1.930% | -45.355% |
iShares Core DAX® | 1.665% | 1.692% | 18.093% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% |
According to Lokrim what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Lokrim for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Sell Karyopharm Therapeutics Inc.
In the thread Trading Karyopharm Therapeutics Inc.
Sell beendet
Stopped prediction by Lokrim for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
05.02.24
05.02.24
-
05.02.25
05.02.25
-41.77%
17.08.24
17.08.24
Risky Investment
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.60
08.04.20
08.04.20
-
04.11.21
04.11.21
-60.19%
05.11.21
05.11.21
Risky Investment